GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zenith Drugs Ltd (NSE:ZENITHDRUG) » Definitions » Total Assets

Zenith Drugs (NSE:ZENITHDRUG) Total Assets : ₹1,436 Mil (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Zenith Drugs Total Assets?

Zenith Drugs's Total Assets for the quarter that ended in Sep. 2024 was ₹1,436 Mil.

During the past 12 months, Zenith Drugs's average Total Assets Growth Rate was 30.80% per year. During the past 3 years, the average Total Assets Growth Rate was 40.20% per year.

During the past 4 years, Zenith Drugs's highest 3-Year average Total Assets Growth Rate was 40.20%. The lowest was 40.20%. And the median was 40.20%.

Total Assets is connected with ROA %. Zenith Drugs's annualized ROA % for the quarter that ended in Sep. 2024 was 8.21%. Total Assets is also linked to Revenue through Asset Turnover. Zenith Drugs's Asset Turnover for the quarter that ended in Sep. 2024 was 0.49.

Zenith Drugs Total Assets Historical Data

The historical data trend for Zenith Drugs's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zenith Drugs Total Assets Chart

Zenith Drugs Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Total Assets
465.47 685.85 979.25 1,350.38

Zenith Drugs Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24 Sep24
Total Assets Get a 7-Day Free Trial 685.85 979.25 1,124.90 1,350.38 1,436.28

Zenith Drugs Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Zenith Drugs's Total Assets for the fiscal year that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (A: Mar. 2024 )+Total Liabilities (A: Mar. 2024 )
=623.325+727.05
=1,350

Zenith Drugs's Total Assets for the quarter that ended in Sep. 2024 is calculated as

Total Assets=Total Equity (Q: Sep. 2024 )+Total Liabilities (Q: Sep. 2024 )
=679.373+756.91
=1,436

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zenith Drugs  (NSE:ZENITHDRUG) Total Assets Explanation

Total Assets is connected with ROA %.

Zenith Drugs's annualized ROA % for the quarter that ended in Sep. 2024 is

ROA %=Net Income (Q: Sep. 2024 )/( (Total Assets (Q: Mar. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=114.374/( (1350.375+1436.283)/ 2 )
=114.374/1393.329
=8.21 %

Note: The Net Income data used here is two times the semi-annual (Sep. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Zenith Drugs's Asset Turnover for the quarter that ended in Sep. 2024 is

Asset Turnover
=Revenue (Q: Sep. 2024 )/( (Total Assets (Q: Mar. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=676.948/( (1350.375+1436.283)/ 2 )
=676.948/1393.329
=0.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Zenith Drugs Total Assets Related Terms

Thank you for viewing the detailed overview of Zenith Drugs's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Zenith Drugs Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zenith Drugs Ltd (NSE:ZENITHDRUG) » Definitions » Total Assets
Comparable Companies
BOM:506128 BOM:540686 BOM:532637 BOM:537536 NSE:SOTAC BOM:524824 BOM:524202 BOM:532384 BOM:531592 NSE:PAR ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
N/A
Address
K. No. 72 / 5, Village Muradpura, NA Depalpur, Indore, MP, IND, 453001
Website
https://www.zenithdrugs.com
Zenith Drugs Ltd is a pharmaceutical manufacturing and trading company. It offers a wide range of formulations in various forms such as ORS Powder, Liquid Orals, Ointments, Liquid Externals, and Capsules. It is also into Generic Medicines.

Zenith Drugs Headlines

No Headlines